Literature DB >> 31430747

Intracranial Myxoid Mesenchymal Tumor with Rare EWSR1-CREM Translocation.

Michael D White1, Michael M McDowell2, Thomas M Pearce3, Andrew J Bukowinski4, Stephanie Greene2.   

Abstract

Translocations between EWSR1 and members of the CREB family of transcription factors (CREB1, ATF1, and CREM) are rare genetic findings occurring in various sarcomas. Of these, the EWSR1-CREM translocation is the most rarely reported. We present the case of a 9-year-old boy who presented with a year of fatigue, weight loss, and abulia. A brain MRI revealed a frontal interhemispheric tumor arising from the falx. After resection, pathology demonstrated a myxoid mesenchymal tumor with an EWSR1-CREM translocation. A series of recent reports of similar tumors has generated ongoing debate in the literature over the classification of these tumors either as intracranial angiomatoid fibrous histiocytomas, which also harbor EWSR1-CREB family translocations, or as a novel diagnostic entity. The present case provides another example of the rare EWSR1-CREM fusion in an intracranial myxoid mesenchymal tumor that recurred in just 6 months despite gross total resection. The findings are discussed in the context of the existing literature and the ongoing effort to appropriately classify this type of tumor.
© 2019 S. Karger AG, Basel.

Entities:  

Keywords:  EWSR1; EWSR1-CREM; Myxoid tumor; Pediatric brain tumors

Mesh:

Substances:

Year:  2019        PMID: 31430747     DOI: 10.1159/000501695

Source DB:  PubMed          Journal:  Pediatr Neurosurg        ISSN: 1016-2291            Impact factor:   1.162


  11 in total

1.  Intracranial angiomatoid fibrous histiocytoma with rhabdoid features: a mimic of rhabdoid meningioma.

Authors:  M Adelita Vizcaino; Caterina Giannini; Howard T Chang; Benjamin R Kipp; Karen Fritchie; Rachael Vaubel
Journal:  Brain Tumor Pathol       Date:  2021-01-12       Impact factor: 3.298

2.  Detection of sarcoma fusions by a next-generation sequencing based-ligation-dependent multiplex RT-PCR assay.

Authors:  Marie-Delphine Lanic; François Le Loarer; Vinciane Rainville; Vincent Sater; Mathieu Viennot; Ludivine Beaussire; Pierre-Julien Viailly; Emilie Angot; Isabelle Hostein; Fabrice Jardin; Philippe Ruminy; Marick Laé
Journal:  Mod Pathol       Date:  2022-01-24       Impact factor: 7.842

3.  Clinicopathological and Genomic Features of Pediatric Intracranial Myxoid Mesenchymal Tumor with both of EWSR1-CREM Gene Fusion and MAP3K13 Mutation: A Case Report and Comparison with Adult Cases in the Literature.

Authors:  Minami Sasaki; Seiichiro Hirono; Yue Gao; Izumi Suda; Tomoo Matsutani; Masayuki Ota; Takashi Kishimoto; Jun-Ichiro Ikeda; Hideaki Yokoo; Yasuo Iwadate
Journal:  NMC Case Rep J       Date:  2022-05-18

4.  Intracranial Myxoid Mesenchymal Tumor/Myxoid Subtype Angiomatous Fibrous Histiocytoma: Diagnostic and Prognostic Challenges.

Authors:  Ricardo A Domingo; Tito Vivas-Buitrago; Mark Jentoft; Alfredo Quinones-Hinojosa
Journal:  Neurosurgery       Date:  2020-12-15       Impact factor: 4.654

5.  Intracranial non-myxoid angiomatoid fibrous histiocytoma with EWSR1-CREB1 transcript fusion treated with doxorubicin: A case report.

Authors:  Louis Garnier; Tanguy Fenouil; Daniel Pissaloux; Roxana Ameli; François Ducray; David Meyronet; Jerome Honnorat
Journal:  Mol Clin Oncol       Date:  2021-05-09

6.  A novel SMARCA2-CREM fusion: expanding the molecular spectrum of intracranial mesenchymal tumors beyond the FET genes.

Authors:  Arnault Tauziède-Espariat; Gaëlle Pierron; Delphine Guillemot; Philipp Sievers; Dominique Cazals-Hatem; Thierry Faillot; Alexandre Roux; Joseph Benzakoun; Sophie Bockel; Nicolas Weinbreck; Lauren Hasty; Emmanuèle Lechapt; Fabrice Chrétien; Pascale Varlet
Journal:  Acta Neuropathol Commun       Date:  2021-10-29       Impact factor: 7.801

Review 7.  The oncogenic fusion landscape in pediatric CNS neoplasms.

Authors:  Mieke Roosen; Zelda Odé; Jens Bunt; Marcel Kool
Journal:  Acta Neuropathol       Date:  2022-02-15       Impact factor: 15.887

8.  Intracranial mesenchymal tumor with FET-CREB fusion-A unifying diagnosis for the spectrum of intracranial myxoid mesenchymal tumors and angiomatoid fibrous histiocytoma-like neoplasms.

Authors:  Emily A Sloan; Jason Chiang; Javier E Villanueva-Meyer; Sanda Alexandrescu; Jennifer M Eschbacher; Wesley Wang; Manuela Mafra; Nasir Ud Din; Emily Carr-Boyd; Michael Watson; Michael Punsoni; Angelica Oviedo; Ahmed Gilani; Bette K Kleinschmidt-DeMasters; Dylan J Coss; M Beatriz Lopes; Corey Raffel; Mitchel S Berger; Susan M Chang; Alyssa Reddy; Biswarathan Ramani; Sean P Ferris; Julieann C Lee; Jeffrey W Hofmann; Soo-Jin Cho; Andrew E Horvai; Melike Pekmezci; Tarik Tihan; Andrew W Bollen; Fausto J Rodriguez; David W Ellison; Arie Perry; David A Solomon
Journal:  Brain Pathol       Date:  2021-01-28       Impact factor: 6.508

Review 9.  The spectrum of rare central nervous system (CNS) tumors with EWSR1-non-ETS fusions: experience from three pediatric institutions with review of the literature.

Authors:  Oscar Lopez-Nunez; Barbara Cafferata; Mariarita Santi; Sarangarajan Ranganathan; Thomas M Pearce; Scott M Kulich; Kelly M Bailey; Alberto Broniscer; Sabrina Rossi; Angelica Zin; MacLean P Nasrallah; Marilyn M Li; Yiming Zhong; Evelina Miele; Rita Alaggio; Lea F Surrey
Journal:  Brain Pathol       Date:  2020-11-06       Impact factor: 6.508

10.  An integrative histopathological and epigenetic characterization of primary intracranial mesenchymal tumors, FET:CREB-fused broadening the spectrum of tumor entities in comparison with their soft tissue counterparts.

Authors:  Arnault Tauziède-Espariat; Philipp Sievers; Frédérique Larousserie; Joseph Benzakoun; Delphine Guillemot; Gaëlle Pierron; Mathilde Duchesne; Emmanuelle Uro-Coste; Alexandre Roux; Alexandre Vasiljevic; Tanguy Fenouil; David Meyronet; Karima Mokhtari; Marc Polivka; Audrey Rousseau; Frédérique Bost-Bezeaud; Samir Akoury; Johan Pallud; Chiara Benevello; Lauren Hasty; Albane Gareton; Emmanuèle Lechapt; Fabrice Chrétien; Thomas Blauwblomme; Kévin Beccaria; Stéphanie Puget; Felix Sahm; Pascale Varlet
Journal:  Brain Pathol       Date:  2021-07-27       Impact factor: 6.508

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.